您好, 歡迎來(lái)到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:深圳欣博盛生物科技有限公司>>抗體>>內(nèi)參抗體>> InVivoMab anti-human PD-1 (CD279)
參 考 價(jià) | 面議 |
產(chǎn)品型號(hào)
品 牌BioxCell
廠商性質(zhì)代理商
所 在 地深圳市
更新時(shí)間:2022-01-27 15:10:06瀏覽次數(shù):772次
聯(lián)系我時(shí),請(qǐng)告知來(lái)自 化工儀器網(wǎng)InVivoMab anti-human CD25 (IL-2Rα)
供貨周期 | 一個(gè)月 | 規(guī)格 | 1mg |
---|---|---|---|
貨號(hào) | BE0188-1MG | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
主要用途 | 科研 |
The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1's structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.
產(chǎn)品名稱:InVivoMab anti-human PD-1 (CD279)
反應(yīng)種屬:human
宿主來(lái)源:mouse
實(shí)驗(yàn)應(yīng)用:in vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice
同種型:IgG1, κ
克隆性:Monoclonal
克隆號(hào):J116
產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml
保存溫度:Undiluted at 4°C in the dark
運(yùn)輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit
預(yù)期分子量:150 kDa
產(chǎn)品形式:液體
有效期:One year from the date of receipt if stored as recommended
產(chǎn)地:美國(guó)
如需購(gòu)買(mǎi)或咨詢Bioxcell公司的產(chǎn)品,請(qǐng)聯(lián)系Bioxcell*代理商欣博盛生物
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。